Table 3. Safety outcomes between Dofetilide and Sotalol groups - Adverse events (n = 378).

Data were represented as counts (percentage)

Adverse events	Dofetilide (n = 298)	Sotalol (n = 80)	p value
Bradyarrhythmias
Bradycardia (HR < 60)	22 (7.4%)	9 (11.3%)	0.26
Sinus pause > 2 secs	0 (0%)	0 (0%)	-
High grade AVB	6 (2.0%)	2 (2.5%)	0.67
Ventricular arrhythmias
New onset PVCs	0 (0%))	0 (0%)	-
Non Sustained VT	7 (2.3%)	1 (1.3%)	1.00
Torsades de pointes (TdP)	4 (1.3%)	1 (1.2%)	1.00
Ventricular fibrillation (VF)	0 (0%)	0 (0%)	-
Drug Discontinuation	24 (8.8%)	4 (5%)	0.47